Sterling Global Strategies »

Halozyme Therapeutics shares owned by Sterling Global Strategies

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Sterling Global Strategies from 13F filings

Historical chart of Sterling Global Strategies investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Sterling Global Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Sterling Global Strategies

Quarter filed Position value Share count Share price at filing
2019-03-31 $354k 22k 16.09
2018-12-31 $322k 22k 14.63
2018-09-30 $400k 22k 18.18
2018-06-30 $371k 22k 16.86
2018-03-31 $431k 22k 19.59
2017-12-31 $446k 22k 20.27
2017-09-30 $382k 22k 17.36
2017-06-30 $282k 22k 12.82
2017-03-31 $285k 22k 12.95
2016-12-31 $217k 22k 9.86
2016-09-30 $266k 22k 12.09
2016-06-30 $190k 22k 8.64
2016-03-31 $208k 22k 9.45
2015-12-31 $381k 22k 17.32
2015-09-30 $295k 22k 13.41
2015-06-30 $271k 12k 22.58
2015-03-31 $171k 12k 14.25
2014-12-31 $116k 12k 9.67